| Importance of standardizing the dose in hyperthermic intraperitoneal chemotherapy (HIPEC): a pharmacodynamic point of view MI Mas-Fuster, A Ramon-Lopez, R Nalda-Molina Cancer chemotherapy and pharmacology 72, 273-274, 2013 | 18 | 2013 |
| Population pharmacokinetics of oxaliplatin after intraperitoneal administration with hyperthermia in Wistar rats MI Mas-Fuster, A Ramon-Lopez, FJ Lacueva, A Arroyo, P Más-Serrano, ... European Journal of Pharmaceutical Sciences 119, 22-30, 2018 | 7 | 2018 |
| Impact of Laparotomy and Intraperitoneal Hyperthermic Instillation (LIHI) on the oxaliplatin pharmacokinetics after intravenous administration in Wistar rats MI Mas-Fuster, A Ramon-Lopez, J Lacueva, A Compañ, P Más-Serrano, ... Cancer chemotherapy and pharmacology 79, 621-627, 2017 | 2 | 2017 |
| Suitability of the AUC Ratio as an Indicator of the Pharmacokinetic Advantage in HIPEC MI Mas-Fuster, A Ramon-Lopez, J Lacueva, P Más-Serrano, ... Journal of Pharmaceutical Sciences 107 (2), 764-769, 2018 | | 2018 |
| Evaluación farmacocinética del oxaliplatino intraperitoneal hipertérmico en rata wistar MI Mas Fuster Evaluación farmacocinética del oxaliplatino intraperitoneal hipertérmico en …, 2017 | | 2017 |
| Population Pharmacokinetics of Hyperthermic Intraoperative Peritoneal Oxaliplatin in Wistar Rats A Ramón-López, MI Mas-Fuster, FJ Lacueva, P Más-Serrano, ... | | |
